埃尔德海姆-切斯特病伪装成白血病:比移植的需要更聪明
William A Ketterer1, Joshua Scott2, Zachary Gillooly3
1Internal Medicine, Wright State University, Dayton, USA.
Cureus
|October 17, 2025
概括
埃尔德海姆 - 切斯特病 (ECD) 是一种罕见的囊细胞病. 这种病例突出显示了一种RAS阳性的ECD,具有非典型的症状,通过针对KRAS通路的MEK抑制成功管理.
科学领域:
- 胰岛细胞瘤和罕见的新生体.
- 瘤学和血液学
- 在罕见疾病的分子诊断.
背景情况:
- 埃尔德海姆 - 切斯特病 (ECD) 是一种罕见的非朗格汉斯细胞囊炎,其特征是囊细胞透到多个器官.
- 脑电阻病的临床表现非常可变,取决于受影响的器官系统,包括骨,中枢神经系统,皮肤,脏和血管系统,这使得诊断具有挑战性.
- 虽然KRAS突变比BRAF突变少见,但在ECD病例的一个子集中被发现.
研究的目的:
- 提出一个具有挑战性的埃尔德海姆 - 切斯特病病例,具有非典型的表现和KRAS突变.
- 讨论EDD的可变表现所带来的诊断困难.
- 以突出使用向治疗成功管理RAS阳性ECD.
主要方法:
- 一个54岁的男性病例报告,病史复杂,症状不一致.
- 诊断工作包括骨髓活检,皮肤活检和正子发射断层扫描 (PET) 成像.
- 分子分析揭示了骨髓活检中的KRAS突变.
主要成果:
- 这位患者出现了牛皮形病变,桑泰拉斯马,反复,关节痛,多发性液和扩散性骨疼痛.
- 骨髓活检显示KRAS突变,最初引起了人们对慢性骨髓单细胞白血病 (CMML) 的怀疑.
- 皮肤活检证实了与桑泰拉斯马相符的泡性囊性透,PET成像显示了扩散的轴性骨吸收.
结论:
- 这一案例凸显了埃德海姆-切斯特病的诊断挑战,原因是它的多样性和通常非典型的表现.
- 在ECD中存在KRAS突变,虽然不太常见,但在临床上是显著的,并且可以接受向治疗.
- 针对KRAS通路的MEK抑制的管理与RAS阳性ECD的当前建议保持一致,表明了个性化的治疗方法.
关键词:
这是一个BRAF负值.慢性骨髓单细胞白血病 (cmml) 是一种科比美丁尼布 (cobimetinib) 是一种埃尔德海姆-切斯特病 (ECD) 是一种纤维性多发性炎的发生.质细胞形成的原因是histiocytosis克拉斯基基突变 克拉斯基突变单细胞化 (monocytosis) 是一种疾病.中性变质症 中性变质症 中性变质症桑泰拉斯马 (Xanthelasma) 是一种神经疾病.更多相关视频
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
8.3K
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.9K
相关概念视频
Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
Tissue Transplantation
894
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
894
Cell-mediated Immune Responses
83.4K
Overview
83.4K
Kidney Transplant I: Introduction
339
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
339
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
